celiprolol has been researched along with Glaucoma, Suspect in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celiprolol (5%) was compared to timolol (0." | 2.66 | Celiprolol versus timolol and placebo: a two week double-blind comparison. ( Caprioli, J; Elman, J; Mead, A; Petillo, J; Rosanelli, EG; Sears, M; Shields, R, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elman, J | 1 |
| Caprioli, J | 1 |
| Rosanelli, EG | 1 |
| Shields, R | 1 |
| Mead, A | 1 |
| Sears, M | 1 |
| Petillo, J | 1 |
1 trial available for celiprolol and Glaucoma, Suspect
| Article | Year |
|---|---|
Celiprolol versus timolol and placebo: a two week double-blind comparison.
Topics: Adrenergic beta-Antagonists; Celiprolol; Clinical Trials as Topic; Double-Blind Method; Female; Glau | 1987 |